freedom has been researched along with Diabetes Mellitus, Adult-Onset in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gerstein, HC; Kristensen, SL; Lee, MMY; McMurray, JJV; Sattar, N | 1 |
1 review(s) available for freedom and Diabetes Mellitus, Adult-Onset
| Article | Year |
|---|---|
Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial.
Topics: Cardiovascular Diseases; Diabetes Mellitus, Type 2; Freedom; Glucagon-Like Peptide-1 Receptor; Humans; Hypoglycemic Agents | 2022 |